Mirae Asset Global Investments’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.4K | Buy |
3,298
+452
| +16% | +$4.17K | ﹤0.01% | 1330 |
|
|
2025
Q1 | $24.8K | Buy |
2,846
+20
| +0.7% | +$174 | ﹤0.01% | 1364 |
|
|
2024
Q4 | $34.2K | Sell |
2,826
-241
| -8% | -$2.92K | ﹤0.01% | 1331 |
|
|
2024
Q3 | $17.4K | Buy |
3,067
+540
| +21% | +$3.07K | ﹤0.01% | 1451 |
|
|
2024
Q2 | $10.8K | Sell |
2,527
-52,323
| -95% | -$224K | ﹤0.01% | 1456 |
|
|
2024
Q1 | $383K | Buy |
54,850
+12,728
| +30% | +$88.9K | ﹤0.01% | 2010 |
|
|
2023
Q4 | $392K | Sell |
42,122
-683
| -2% | -$6.36K | ﹤0.01% | 2086 |
|
|
2023
Q3 | $280K | Sell |
42,805
-3,187
| -7% | -$20.9K | ﹤0.01% | 2156 |
|
|
2023
Q2 | $371K | Sell |
45,992
-5,732
| -11% | -$46.3K | ﹤0.01% | 2082 |
|
|
2023
Q1 | $443K | Buy |
51,724
+17,579
| +51% | +$151K | ﹤0.01% | 1985 |
|
|
2022
Q4 | $316K | Buy |
34,145
+4,507
| +15% | +$41.7K | ﹤0.01% | 2133 |
|
|
2022
Q3 | $306K | Buy |
29,638
+8,641
| +41% | +$89.2K | ﹤0.01% | 2148 |
|
|
2022
Q2 | $210K | Buy |
+20,997
| New | +$210K | ﹤0.01% | 2134 |
|